Atossa Genetics Inc., a Seattle-based biopharmaceutical company, changed its name to Atossa Therapeutics Inc.
The company said the name change more clearly reflects its focus on developing therapies for breast cancer, breast density and other breast conditions.
Atossa's common stock will continue to trade on the NasdaqCM exchange under the ATOS symbol.